Toll-like receptor 4-induced IL-22 accelerates kidney regeneration

Journal of the American Society of Nephrology

Volumn 25, Issue 5, 2014, Pages 978-989

  Kulkarni, Onkar P ^a   Hartter, Ingo ^a   Mulay, Shrikant R ^a   Hagemann, Jan ^a   Darisipudi, Murthy N ^a   Kumar Vr, Santhosh ^a   Romoli, Simone ^a   Thomasova, Dana ^a   Ryu, Mi ^a   Kobold, Sebastian ^b   Anders, Hans Joachim ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b UNIVERSITY OF MUNICH   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 22; INTERLEUKIN 22 RECEPTOR; INTERLEUKIN RECEPTOR; JANUS KINASE 3; MITOGEN ACTIVATED PROTEIN KINASE 1; PATTERN RECOGNITION RECEPTOR; STAT3 PROTEIN; TOLL LIKE RECEPTOR 4; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG; INTERLEUKIN DERIVATIVE; INTERLEUKIN-22; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; STAT3 PROTEIN, MOUSE; TLR4 PROTEIN, MOUSE;

ACUTE KIDNEY FAILURE; ARTICLE; CELL ISOLATION; CELL LEVEL; CELL PROTECTION; CELL REGENERATION; CYTOKINE RELEASE; DENDRITIC CELL; EPITHELIZATION; IN VITRO STUDY; KIDNEY TUBULE CELL; KIDNEY TUBULE NECROSIS; MACROPHAGE; MONONUCLEAR CELL; MONONUCLEAR PHAGOCYTE; MOUSE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DEPLETION; PROTEIN EXPRESSION; PROTEIN ISOLATION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; UREA NITROGEN BLOOD LEVEL; ANIMAL; BIOSYNTHESIS; C57BL MOUSE; CYTOLOGY; KIDNEY TUBULE; METABOLISM; PATHOLOGY; PHYSIOLOGY; REGENERATION; REPERFUSION INJURY; SECRETION (PROCESS); UROTHELIUM;

ACUTE KIDNEY INJURY; ANIMALS; EXTRACELLULAR SIGNAL-REGULATED MAP KINASES; INTERLEUKINS; JANUS KINASES; KIDNEY TUBULES; MAP KINASE SIGNALING SYSTEM; MICE; MICE, INBRED C57BL; MONONUCLEAR PHAGOCYTE SYSTEM; REGENERATION; REPERFUSION INJURY; STAT3 TRANSCRIPTION FACTOR; TOLL-LIKE RECEPTOR 4; UROTHELIUM;

EID: 84906539304     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2013050528     Document Type: Article

References (57)

1. Bonventre JV, Yang L: Cellular pathophysiology of ischemic acute kidney injury. J Clin Invest 121: 4210-4221, 2011
2. Wu H, Ma J, Wang P, Corpuz TM, Panchapakesan U, Wyburn KR, Chadban SJ:HMGB1 contributes to kidney ischemia reperfusion injury. J Am Soc Nephrol 21: 1878-1890, 2010
3. Allam R, Scherbaum CR, Darisipudi MN, Mulay SR, Hägele H, Lichtnekert J, Hagemann JH, Rupanagudi KV, Ryu M, Schwarzenberger C, Hohenstein B, Hugo C, Uhl B, Reichel CA, Krombach F,MonestierM, Liapis H, Moreth K, Schaefer L, Anders HJ: Histones from dying renal cells aggravate kidney injury via TLR2 and TLR4. J Am Soc Nephrol 23: 1375-1388, 2012
4. Rabadi MM, Ghaly T, Goligorksy MS, Ratliff BB: HMGB1 in renal ischemic injury. Am J Physiol Renal Physiol 303: F873-F885, 2012
5. Rabadi MM, Kuo MC, Ghaly T, Rabadi SM, Weber M, Goligorsky MS, Ratliff BB: Interaction between uric acid and HMGB1 translocation and release from endothelial cells. Am J Physiol Renal Physiol 302: F730-F741, 2012
6. DarisipudiMN, Thomasova D,Mulay SR, Brech D,Noessner E, Liapis H, Anders HJ: Uromodulin triggers IL-1b-dependent innate immunity via the NLRP3 inflammasome. J Am Soc Nephrol 23: 1783-1789, 2012
7. Säemann MD, Weichhart T, Zeyda M, Staffler G, Schunn M, Stuhlmeier KM, Sobanov Y, Stulnig TM, Akira S, von Gabain A, von Ahsen U, Hörl WH, Zlabinger GJ: Tamm-Horsfall glycoprotein links innate immune cell activation with adaptive immunity via a Toll-like receptor-4-dependent mechanism. J Clin Invest 115: 468-475, 2005
8. Anders HJ, Muruve DA: The inflammasomes in kidney disease. J Am Soc Nephrol 22: 1007-1018, 2011
9. Anders HJ: Toll-like receptors and danger signaling in kidney injury. J Am Soc Nephrol 21: 1270-1274, 2010
10. Anders HJ, Vielhauer V, Schlöndorff D: Chemokines and chemokine receptors are involved in the resolution or progression of renal disease. Kidney Int 63: 401-415, 2003
11. Bonventre JV, Zuk A: Ischemic acute renal failure: An inflammatory disease? Kidney Int 66: 480-485, 2004
12. Bonventre JV: Pathophysiology of acute kidney injury: Roles of potential inhibitors of inflammation. Contrib Nephrol 156: 39-46, 2007
13. Lech M, Avila-Ferrufino A, Allam R, Segerer S, Khandoga A, Krombach F, Garlanda C, Mantovani A, Anders HJ: Resident dendritic cells prevent postischemic acute renal failure by help of single Ig IL-1 receptorrelated protein. J Immunol 183: 4109-4118, 2009
14. Lassen S, Lech M, Römmele C, Mittruecker HW, Mak TW, Anders HJ: Ischemia reperfusion induces IFN regulatory factor 4 in renal dendritic cells, which suppresses postischemic inflammation and prevents acute renal failure. J Immunol 185: 1976-1983, 2010
15. LechM, Römmele C, Gröbmayr R, Eka Susanti H, KulkarniOP,Wang S, Gröne HJ, Uhl B, Reichel C, Krombach F, Garlanda C, Mantovani A, Anders HJ: Endogenous and exogenous pentraxin-3 limits postischemic acute and chronic kidney injury. Kidney Int 83: 647-661, 2013
16. Chen J, Matzuk MM, Zhou XJ, Lu CY: Endothelial pentraxin 3 contributes to murine ischemic acute kidney injury. Kidney Int 82: 1195-1207, 2012
17. Anders HJ, Ryu M: Renal microenvironments and macrophage phenotypes determine progression or resolution of renal inflammation and fibrosis. Kidney Int 80: 915-925, 2011
18. Lee S, Huen S,Nishio H,Nishio S, LeeHK,Choi BS, Ruhrberg C,Cantley LG: Distinct macrophage phenotypes contribute to kidney injury and repair. J Am Soc Nephrol 22: 317-326, 2011
19. Zhang MZ, Yao B, Yang S, Jiang L, Wang S, Fan X, Yin H, Wong K, Miyazawa T, Chen J, Chang I, Singh A, Harris RC: CSF-1 signaling mediates recovery from acute kidney injury. J Clin Invest 122: 4519-4532, 2012
20. Humphreys BD, Bonventre JV:Mesenchymal stemcells in acute kidney injury. Annu Rev Med 59: 311-325, 2008
21. Humphreys BD, Czerniak S, DiRocco DP, Hasnain W, Cheema R, Bonventre JV: Repair of injured proximal tubule does not involve specialized progenitors. Proc Natl Acad Sci U S A 108: 9226-9231, 2011
22. Angelotti ML, Ronconi E, Ballerini L, Peired A,Mazzinghi B, Sagrinati C, Parente E, GacciM, Carini M, Rotondi M, Fogo AB, Lazzeri E, Lasagni L, Romagnani P: Characterization of renal progenitors committed toward tubular lineage and their regenerative potential in renal tubular injury. Stem Cells 30: 1714-1725, 2012
23. Romagnani P: Family portrait: Renal progenitor of Bowman's capsule and its tubular brothers. Am J Pathol 178: 490-493, 2011
24. Lech M, Gröbmayr R, Weidenbusch M, Anders HJ: Tissues use resident dendritic cells and macrophages to maintain homeostasis and to regain homeostasis upon tissue injury: The immunoregulatory role of changing tissue environments. Mediators Inflamm 2012: 951390, 2012
25. Kim MG, Boo CS, Ko YS, Lee HY, ChoWY, Kim HK, Jo SK: Depletion of kidney CD11c+ F4/80+ cells impairs the recovery process in ischaemia/reperfusion-induced acute kidney injury. Nephrol Dial Transplant 25: 2908-2921, 2010
26. Isbel NM, Hill PA, Foti R,Mu W, Hurst LA, Stambe C, Lan HY, Atkins RC, Nikolic-Paterson DJ: Tubules are the major site ofM-CSF production in experimental kidney disease: Correlation with local macrophage proliferation. Kidney Int 60: 614-625, 2001
27. Lech M, Anders HJ: Macrophages and fibrosis: How resident and infiltrating mononuclear phagocytes orchestrate all phases of tissue injury and repair. Biochim Biophys Acta 1832: 989-997, 2013
28. Hagemann JH, Thomasova D, Mulay SR, Anders HJ: Nrf2 signalling promotes ex vivo tubular epithelial cell survival and regeneration via murine double minute (MDM)-2. Nephrol Dial Transplant 28: 2028-2037, 2013
29. Mulay SR, Thomasova D, Ryu M, Anders HJ: MDM2 (murine double minute-2) links inflammation and tubular cell healing during acute kidney injury in mice. Kidney Int 81: 1199-1211, 2012
30. Wu H, Chen G, Wyburn KR, Yin J, Bertolino P, Eris JM, Alexander SI, Sharland AF, Chadban SJ: TLR4 activation mediates kidney ischemia/reperfusion injury. J Clin Invest 117: 2847-2859, 2007
31. Gurtner GC, Werner S, Barrandon Y, Longaker MT: Wound repair and regeneration. Nature 453: 314-321, 2008
32. Anders HJ: Four danger response programs determine glomerular and tubulointerstitial kidney pathology: Clotting, inflammation, epithelial and mesenchymal healing. Organogenesis 8: 29-40, 2012
33. Sonnenberg GF, Fouser LA, Artis D: Border patrol: Regulation of immunity, inflammation and tissue homeostasis at barrier surfaces by IL-Nat Immunol 12: 383-390, 2011
34. Zheng Y, Danilenko DM, Valdez P, Kasman I, Eastham-Anderson J, Wu J, Ouyang W: Interleukin-22, a T(H)17 cytokine, mediates IL-23-induced dermal inflammation and acanthosis. Nature 445: 648-651, 2007
35. Sa SM, Valdez PA, Wu J, Jung K, Zhong F, Hall L, Kasman I, Winer J, Modrusan Z, Danilenko DM, Ouyang W: The effects of IL-20 subfamily cytokines on reconstituted human epidermis suggest potential roles in cutaneous innate defense and pathogenic adaptive immunity in psoriasis. J Immunol 178: 2229-2240, 2007
36. Aujla SJ, Chan YR, Zheng M, FeiM, Askew DJ, Pociask DA, Reinhart TA, McAllister F, Edeal J, Gaus K, Husain S, Kreindler JL, Dubin PJ, Pilewski JM, Myerburg MM, Mason CA, Iwakura Y, Kolls JK: IL-22 mediates mucosal host defense against Gram-negative bacterial pneumonia. Nat Med 14: 275-281, 2008
37. Sugimoto K,Ogawa A, Mizoguchi E, Shimomura Y, Andoh A, Bhan AK, Blumberg RS, Xavier RJ, Mizoguchi A: IL-22 ameliorates intestinal inflammation in a mouse model of ulcerative colitis. J Clin Invest 118: 534-544, 2008
38. Pickert G, Neufert C, Leppkes M, Zheng Y, Wittkopf N, Warntjen M, Lehr HA, Hirth S,Weigmann B, Wirtz S,OuyangW, NeurathMF, Becker C: STAT3 links IL-22 signaling in intestinal epithelial cells to mucosal wound healing. J ExpMed 206: 1465-1472, 2009
39. Radaeva S, Sun R, Pan HN, Hong F, Gao B: Interleukin 22 (IL-22) plays a protective role in T cell-mediated murine hepatitis: IL-22 is a survival factor for hepatocytes via STAT3 activation. Hepatology 39: 1332-1342, 2004
40. Zenewicz LA, Yancopoulos GD, Valenzuela DM, Murphy AJ, Karow M, Flavell RA: Interleukin-22 but not interleukin-17 provides protection to hepatocytes during acute liver inflammation. Immunity 27: 647-659, 2007
41. Dudakov JA, Hanash AM, Jenq RR, Young LF, Ghosh A, Singer NV, West ML, Smith OM, Holland AM, Tsai JJ, Boyd RL, van den Brink MR: Interleukin-22 drives endogenous thymic regeneration inmice. Science 336: 91-95, 2012
42. Lejeune D, Dumoutier L, Constantinescu S, Kruijer W, Schuringa JJ, Renauld JC: Interleukin-22 (IL-22) activates the JAK/STAT, ERK, JNK, and p38MAP kinase pathways in a rat hepatoma cell line. Pathways that are shared with and distinct fromIL-10. J Biol Chem277: 33676-33682, 2002
43. Cella M, Fuchs A, Vermi W, Facchetti F, Otero K, Lennerz JK, Doherty JM, Mills JC, Colonna M: A human natural killer cell subset provides an innate source of IL-22 for mucosal immunity. Nature 457: 722-725, 2009
44. Duhen T, Geiger R, Jarrossay D, Lanzavecchia A, Sallusto F: Production of interleukin 22 but not interleukin 17 by a subset of human skinhoming memory T cells. Nat Immunol 10: 857-863, 2009
45. Zheng Y, Valdez PA, Danilenko DM, Hu Y, Sa SM, Gong Q, Abbas AR, Modrusan Z, Ghilardi N, de Sauvage FJ, Ouyang W: Interleukin-22 mediates early host defense against attaching and effacing bacterial pathogens. Nat Med 14: 282-289, 2008
46. Nelson PJ, Rees AJ, GriffinMD, Hughes J, Kurts C, Duffield J: The renal mononuclear phagocytic system.JAm Soc Nephrol 23: 194-203, 2012
47. Rock KL, Latz E, Ontiveros F, Kono H: The sterile inflammatory response. Annu Rev Immunol 28: 321-342, 2010
48. Rakoff-Nahoum S, Paglino J, Eslami-Varzaneh F, Edberg S, Medzhitov R: Recognition of commensal microflora by toll-like receptors is required for intestinal homeostasis. Cell 118: 229-241, 2004
49. Dasu MR, Isseroff RR: Toll-like receptors in wound healing: Location, accessibility, and timing. J Invest Dermatol 132: 1955-1958, 2012
50. Huebener P, Schwabe RF: Regulation of wound healing and organ fibrosis by toll-like receptors. Biochim Biophys Acta 1832: 1005-1017, 2013
51. Sallustio F, Costantino V, Cox SN, Loverre A, Divella C, RizziM, Schena FP: Human renal stem/progenitor cells repair tubular epithelial cell injury through TLR2-driven inhibin-A and microvesicle-shuttled decorin. Kidney Int 83: 392-403, 2013
52. Sallustio F, De Benedictis L, Castellano G, Zaza G, Loverre A, Costantino V, GrandalianoG, Schena FP: TLR2 plays a role in the activation of human resident renal stem/progenitor cells. FASEB J 24: 514-525, 2010
53. Hanash AM, Dudakov JA, Hua G, O'Connor MH, Young LF, Singer NV, West ML, Jenq RR, Holland AM, Kappel LW, Ghosh A, Tsai JJ, Rao UK, Yim NL, Smith OM, Velardi E, Hawryluk EB, Murphy GF, Liu C, Fouser LA, Kolesnick R, Blazar BR, van den Brink MR: Interleukin-22 protects intestinal stem cells from immune-mediated tissue damage and regulates sensitivity to graft versus host disease. Immunity 37: 339-350, 2012
54. Teixeira VP, Blattner SM, Li M, Anders HJ, Cohen CD, Edenhofer I, Calvaresi N, Merkle M, Rastaldi MP, Kretzler M: Functional consequences of integrin-linked kinase activation in podocyte damage. Kidney Int 67: 514-523, 2005
55. Patole PS, Pawar RD, Lichtnekert J, Lech M, Kulkarni OP, Ramanjaneyulu A, Segerer S, Anders HJ: Coactivation of Toll-like receptor-3 and -7 in immune complex glomerulonephritis. J Autoimmun 29: 52-59, 2007
56. Lech M, Avila-Ferrufino A, Skuginna V, Susanti HE, Anders HJ: Quantitative expression of RIG-like helicase, NOD-like receptor and inflammasome-related mRNAs in humans and mice. Int Immunol 22: 717-728, 2010
57. Mulay SR, Kulkarni OP, Rupanagudi KV, Migliorini A, Darisipudi MN, Vilaysane A, Muruve D, Shi Y, Munro F, Liapis H, Anders HJ: Calcium oxalate crystals induce renal inflammation by NLRP3-mediated IL-1b secretion. J Clin Invest 123: 236-246, 2013